Ethical Challenge and Clinical Issues
The moral implications of enhancement tissue science and regenerative medicine technologies may also alter our perception of the life cycle and of bodily integrity, if the person’s body can be reconstituted and rejuvenated using living material derived from various people, making the person into a hybrid. The aim and mode of their action varies, presenting unique challenges regarding their production, the design and conduct of clinical trials, and their introduction in therapy. The major restraint are clinical trials require that researchers are not sure about the effect of new treatments compare to existing interventions and that the participants consent to treatments. The small understanding about the syntax of tissue regeneration and consequently of short- and long-term effects, risks, and benefits which challenges us to define criteria for the conduct of trials and for achieving genuine informed consent.